NCT01620008 (IBS) is a NA clinical trial of Delayed Cord Clamping in Iron Deficiency, sponsored by University of Rhode Island.

Who is sponsoring NCT01620008?

NCT01620008 is sponsored by University of Rhode Island.

What drugs are being tested in NCT01620008?

Interventions in NCT01620008: Delayed Cord Clamping.

What condition does NCT01620008 study?

NCT01620008 studies Iron Deficiency.

Is NCT01620008 still recruiting?

NCT01620008 is currently completed. Last updated 1 October 2021.

Last reviewed 2021-10-01 · How we verify

NCT01620008: IBS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delayed Cord Clamping and Infant Brain Study

Completed NA Last updated 1 October 2021

What this trial tests

NA trial testing Delayed Cord Clamping in Iron Deficiency in 106 participants. Completed in 31 December 2018.

Timeline

1 October 2012

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	University of Rhode Island
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	106
Start date	1 October 2012
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across United States

Drugs / interventions tested

Delayed Cord Clamping

Conditions studied

Iron Deficiency — all drugs for Iron Deficiency →

Sponsor

University of Rhode Island

Who can join

Adults 18 to 45, female only, with Iron Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if delaying cord clamping at the birth of term infants effects the early brain development (myelin deposition)as determined by quantitative MRI at 4 and 10 months and developmental testing at 4, 10 and 24 months. This study will help to establish a scientific basis for the timing of cord clamping with reference to brain development.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of delayed cord clamping on residual placental blood volume, hemoglobin and bilirubin levels in term infants: a randomized controlled trial.
Mercer JS, Erickson-Owens DA, Collins J, Barcelos MO, et al · · 2017 · cited 54× · PMID 27929530 · DOI 10.1038/jp.2016.222
Effects of Delayed Cord Clamping on 4-Month Ferritin Levels, Brain Myelin Content, and Neurodevelopment: A Randomized Controlled Trial.
Mercer JS, Erickson-Owens DA, Deoni SCL, Dean DC, et al · · 2018 · cited 51× · PMID 30473033 · DOI 10.1016/j.jpeds.2018.06.006
Does Delayed Cord Clamping Improve Long-Term (≥4 Months) Neurodevelopment in Term Babies? A Systematic Review and a Meta-Analysis of Randomized Clinical Trials.
Xodo S, Xodo L, Baccarini G, Driul L, et al · · 2021 · cited 5× · PMID 33912524 · DOI 10.3389/fped.2021.651410

Verify or expand the search:

Other trials of Delayed Cord Clamping

Trials testing the same drug.

NCT03145142 — PREMOD2 With Near Infrared Spectroscopy Sub-study · NA · unknown
NCT01866982 — The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants · NA · completed

Other recruiting trials for Iron Deficiency

Currently open trials in the same condition.

NCT07217873 — IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study · Phase 2, PHASE3 · recruiting
NCT07081152 — Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity · NA · recruiting
NCT07053475 — IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches · Phase 4 · recruiting
NCT06879080 — Maternal Iron Deficiency and Childhood Health · recruiting
NCT06427343 — The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Hea · Phase 4 · recruiting

Other University of Rhode Island trials

Trials by the same sponsor.

NCT06409975 — Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults · NA · recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
NCT06579209 — NAD+ Oral Supplement Pilot Intervention in Adult Females · NA · completed
NCT05380765 — Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents · NA · recruiting
NCT05908253 — Toward a Generalizable Closed-loop Neurofeedback-based BCI for Attention Training · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01620008 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rhode Island
Last refreshed: 1 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01620008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing